137 related articles for article (PubMed ID: 35384875)
1. Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing Analysis.
Pan CC; Tseng CE; Kuroda N; Yano M; Yasuda M; Nagashima Y; Yeh YC; Wang YC; Chang YH; Epstein JI
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):257-263. PubMed ID: 35384875
[TBL] [Abstract][Full Text] [Related]
2. Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.
Wobker SE; Matoso A; Pratilas CA; Mangray S; Zheng G; Lin MT; Debeljak M; Epstein JI; Argani P
Am J Surg Pathol; 2019 Sep; 43(9):1157-1169. PubMed ID: 31192863
[TBL] [Abstract][Full Text] [Related]
3. [Molecular features of metanephric adenoma and their values in differential diagnosis].
Wang X; Shi SS; Yang WR; Ye SB; Li R; Ma HH; Zhang RS; Lu ZF; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):38-42. PubMed ID: 28072975
[No Abstract] [Full Text] [Related]
4. [Clinicopathological features of adult Wilms tumor with BRAF V600E mutation].
Gan HL; Wang QF; Zhu XL; Lyu H; Wang J
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1210-1215. PubMed ID: 38058036
[No Abstract] [Full Text] [Related]
5. KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas.
Catic A; Kurtovic-Kozaric A; Sophian A; Mazur L; Skenderi F; Hes O; Rohan S; Rakheja D; Kogan J; Pins MR
BMC Med Genet; 2020 Oct; 21(1):202. PubMed ID: 33046021
[TBL] [Abstract][Full Text] [Related]
6. BRAF mutations in pediatric metanephric tumors.
Chami R; Yin M; Marrano P; Teerapakpinyo C; Shuangshoti S; Thorner PS
Hum Pathol; 2015 Aug; 46(8):1153-61. PubMed ID: 26014474
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.
Chan E; Stohr BA; Croom NA; Cho SJ; Garg K; Troxell ML; Higgins JP; Bean GR
Histopathology; 2020 Jun; 76(7):1084-1090. PubMed ID: 32064677
[TBL] [Abstract][Full Text] [Related]
8. Atypical metanephric adenoma: Shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms' tumor.
Yin X; Zhang X; Pan X; Tan J; Zheng L; Zhou Q; Chen N
Front Oncol; 2022; 12():1020456. PubMed ID: 36313688
[TBL] [Abstract][Full Text] [Related]
9. Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.
Argani P; Tickoo SK; Matoso A; Pratilas CA; Mehra R; Tretiakova M; Sibony M; Meeker AK; Lin MT; Reuter VE; Epstein JI; Gagan J; Palsgrove DN
Am J Surg Pathol; 2022 Jul; 46(7):988-999. PubMed ID: 35184066
[TBL] [Abstract][Full Text] [Related]
10. BRAF mutations in metanephric adenoma of the kidney.
Choueiri TK; Cheville J; Palescandolo E; Fay AP; Kantoff PW; Atkins MB; McKenney JK; Brown V; Lampron ME; Zhou M; Hirsch MS; Signoretti S
Eur Urol; 2012 Nov; 62(5):917-22. PubMed ID: 22727996
[TBL] [Abstract][Full Text] [Related]
11. Paediatric metanephric tumours: a clinicopathological and molecular characterisation.
de Jel DVC; Hol JA; Ooms AHAG; de Krijger RR; Jongmans MCJ; Littooij AS; Drost J; van Grotel M; van den Heuvel-Eibrink MM
Crit Rev Oncol Hematol; 2020 Jun; 150():102970. PubMed ID: 32371339
[TBL] [Abstract][Full Text] [Related]
12. Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma.
Udager AM; Pan J; Magers MJ; Palapattu GS; Morgan TM; Montgomery JS; Weizer AZ; Hafez KS; Miller DC; Wolf JS; McHugh JB; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Am J Surg Pathol; 2015 Apr; 39(4):549-57. PubMed ID: 25602792
[TBL] [Abstract][Full Text] [Related]
13. Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process.
Lenci N; Francesco P; Scarciglia E; Fiorentino V; Schino M; Palermo G; Racioppi M; Bassi P; Martini M
Med Mol Morphol; 2021 Jun; 54(2):187-191. PubMed ID: 33175195
[TBL] [Abstract][Full Text] [Related]
14. Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases.
Ding Y; Wang C; Li X; Jiang Y; Mei P; Huang W; Song G; Wang J; Ping G; Hu R; Miao C; He X; Chen G; Li H; Zhu Y; Zhang Z
Diagn Pathol; 2018 Aug; 13(1):54. PubMed ID: 30111351
[TBL] [Abstract][Full Text] [Related]
15. BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition.
Obasaju P; Shahab S; Dunn E; Rhee DS; Jiang L; Dome JS; Friedman AD; Argani P; Pratilas CA
Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238401
[TBL] [Abstract][Full Text] [Related]
16. BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors.
Marsden L; Jennings LJ; Gadd S; Yu M; Perlman EJ; Cajaiba MM
Hum Pathol; 2017 Feb; 60():32-36. PubMed ID: 27769870
[TBL] [Abstract][Full Text] [Related]
17. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?
Dadone B; Ambrosetti D; Carpentier X; Duranton-Tanneur V; Burel-Vandenbos F; Amiel J; Pedeutour F
Cancer Genet; 2013; 206(9-10):347-52. PubMed ID: 24432405
[TBL] [Abstract][Full Text] [Related]
18. Metanephric adenoma vs. Wilms' tumor: a report of 2 cases with diagnosis by fine needle aspiration and cytologic comparisons.
Khayyata S; Grignon DJ; Aulicino MR; Al-Abbadi MA
Acta Cytol; 2007; 51(3):464-7. PubMed ID: 17536557
[TBL] [Abstract][Full Text] [Related]
19. Metanephric adenoma: molecular study and review of the literature.
Rodríguez-Zarco E; Machuca-Aguado J; Macías-García L; Vallejo-Benítez A; Ríos-Martín JJ
Oncotarget; 2022; 13():387-392. PubMed ID: 35198098
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of metanephric adenofibroma and related lesions: clinicopathologic study of 25 cases from the National Wilms Tumor Study Group Pathology Center.
Arroyo MR; Green DM; Perlman EJ; Beckwith JB; Argani P
Am J Surg Pathol; 2001 Apr; 25(4):433-44. PubMed ID: 11257617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]